Pages that link to "Item:Q2510014"
Jump to navigation
Jump to search
The following pages link to (Q2510014):
Displayed 5 items.
- Development and scaling of innovative process of therapeutic production, recombinant monoclonal antibody, in order to enable industrial implementation of the first Polish biotechnology drug for oncological and autoimmune therapies. (Q78205) (← links)
- Development of a biotechnology drug by developing an innovative monoclonal antibody of the IgG1 subclass with reduced glycoforms to the reference medicine – against the EGFR (Q78895) (← links)
- Extension of Mabion S.A. Research and Development Centre – research on a new generation of medicines (Q80596) (← links)
- Increasing the competitiveness of Mabion S.A. through the implementation of process innovation. (Q4418453) (← links)
- Development of a panel of analytical methods for immunogenicity characterisation in a clinical trial aimed at patients suffering from rheumatoid arthritis using rituximab as a medicinal substance. (Q4419397) (← links)